adefovir
Sign in to saveAlso known as Adéfovir, 9-(2-phosphonylmethoxyethyl)adenine, 9-(2-(phosphonomethoxy)ethyl)adenine, Adefovirum
Adefovir is a prescription medicine used to treat (chronic) infections with hepatitis B virus. A prodrug form of adefovir was previously called bis-POM PMEA, with trade names Preveon and Hepsera. It is an orally administered nucleotide analog reverse-transcriptase inhibitor (ntRTI). It can be formulated as the pivoxil prodrug adefovir dipivoxil.
Research
2,755 papers- Adefovir for lamivudine-resistant hepatitis B.Antiviral therapy · 2022
- Adefovir-induced hypophosphatemic osteochondrosis mimicks ankylosing spondylitis.International journal of rheumatic diseases · 2024
- Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.Journal of hepatology · 2005
- Adefovir-induced osteomalacia and hypophosphatemia.Medicina clinica · 2022
- Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.Expert review of anti-infective therapy · 2004
via PubMed
~3 min read
Encyclopedic overview
5 sectionsContents
- Uses
- History
- Mechanism of action
- References
- External links
{{Drugbox | Verifiedfields = changed | verifiedrevid = 477242223 | IUPAC_name = {[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphonic acid | image = Adefovir.svg | image_class = skin-invert-image | width = 215
| tradename = Hepsera | Drugs.com = | pregnancy_AU = B3 | pregnancy_US = C | legal_AU = S4 | legal_CA = Rx-only | legal_UK = POM | legal_US = Rx-only | routes_of_administration = Oral
Excerpted from Wikipedia’s “adefovir” article, available under the CC BY-SA 4.0 licence.